Principles in pharmacogenetics.
Roden
D M
DM
Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6602, USA. dan.roden@mcmail.vanderbilt.edu
D000818:Animals; D019389:Cytochrome P-450 CYP2D6 / Q000187:drug effects / Q000235:genetics; D065690:Cytochrome P-450 CYP2D6 Inhibitors; D064420:Drug-Related Side Effects and Adverse Reactions; D005544:Forecasting; D019450:Genes, MDR / Q000235:genetics / Q000502:physiology; D023281:Genomics / Q000639:trends; D016045:Human Genome Project; D006801:Humans; D007473:Ion Channels / Q000235:genetics; D008133:Long QT Syndrome / Q000139:chemically induced / Q000235:genetics; D051379:Mice; D004364:Pharmaceutical Preparations / Q000737:chemistry / Q000378:metabolism; D010597:Pharmacogenetics / Q000639:trends; D010600:Pharmacology / Q000639:trends; D011110:Polymorphism, Genetic
D065690:Cytochrome P-450 CYP2D6 Inhibitors; D007473:Ion Channels; D004364:Pharmaceutical Preparations; D019389:Cytochrome P-450 CYP2D6